Name Development Level Target Family
Vascular endothelial growth factor A Tclin Non-IDG
Epidermal growth factor receptor Tclin Kinase
Name Description
bevacizumab An anti-VEGF recombinant monoclonal antibody consisting of humanized murine antibody. It inhibits VEGF receptors and prevents the proliferation of blood vessels.
TCRDv4.6.0
DrugCentral Indication
DrugCentral
bevacizumab